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Vanillyl-alcohol oxidase (VAO) is member of a newly
recognized flavoprotein family of structurally related
oxidoreductases. The enzyme contains a covalently
linked FAD cofactor. To study the mechanism of flavi-
nylation we have created a design point mutation
(His-61 3 Thr). In the mutant enzyme the covalent His-
C8a-flavin linkage is not formed, while the enzyme is
still able to bind FAD and perform catalysis. The H61T
mutant displays a similar affinity for FAD and ADP (Kd
5 1.8 and 2.1 mM, respectively) but does not interact with
FMN. H61T is about 10-fold less active with 4-(me-
thoxymethyl)phenol) (kcat 5 0.24 s
21, Km 5 40 mM) than
the wild-type enzyme. The crystal structures of both the
holo and apo form of H61T are highly similar to the
structure of wild-type VAO, indicating that binding of
FAD to the apoprotein does not require major structural
rearrangements. These results show that covalent flavi-
nylation is an autocatalytical process in which His-61
plays a crucial role by activating His-422. Furthermore,
our studies clearly demonstrate that in VAO, the FAD
binds via a typical lock-and-key approach to a preorga-
nized binding site.
A substantial part of all biological reactions rely on the
action of cofactor-dependent enzymes. By adding the function-
ality of a cofactor to the protein matrix, enzymes have found a
way of expanding their catalytic power that has led to an
enormous collection of different biocatalysts. For the various
types of cofactors observed in nature, different molecular ap-
proaches of cofactor binding and anchoring have been identi-
fied. Flavoproteins represent one of the major groups of cofactor-
dependent enzymes (1, 2). However, data on the molecular
process of FAD or FMN binding are scarce, while only a limited
number of flavoprotein structures in the apo form are known
(3–5). A striking example of the importance of efficient FAD
binding was recently shown for methylenetetrahydrofolate re-
ductase (6). A commonly found point mutation in the corre-
sponding human gene results in a decreased cofactor affinity,
which can lead to severe inborn health problems e.g. neural-
tube defects and Down syndrome. For a better understanding
of the process of flavin binding, we have started a study on the
process of flavinylation in vanillyl-alcohol oxidase (VAO).1
VAO (EC 1.1.3.38) is a FAD-dependent enzyme capable of
oxidizing a wide range of phenolic substrates providing the
fungus Penicillium simplicissimum with a tool for metabolizing
aromatic compounds (7). The structure of VAO encompasses
560 residues and a fully buried covalently bound FAD cofactor
(Fig. 1) (8). The VAO monomer consists of two a/b domains:
residues 1–270 and 500–560 form a FAD binding domain,
while the intervening residues form the so-called cap domain.
The active site is located in the core of the protein, at the
interface of the two domains with the flavin being covalently
linked to His-422 of the cap domain. From a sequence align-
ment study it was recognized that VAO is a representative of a
novel flavoprotein family, whose members share a conserved
FAD binding domain (9). The recent unforeseen discovery of
the same FAD binding fold in CO dehydrogenase indicates that
this FAD binding module is widespread among flavoproteins
(10).
Recently, we have performed an in-depth study on the role of
the covalent histidyl-FAD bond in VAO (11). Covalent anchor-
ing of a flavin cofactor has been encountered in a variety of
other flavin-dependent oxidoreductases, while the rationale for
this type of cofactor attachment has remained obscure for a
long time (12). Our recent study showed that deletion of the
histidyl bond, by replacing His-422 by an alanine, resulted in
an active VAO variant containing a noncovalently but tightly
bound FAD cofactor. Determination of the structure of this
mutant enzyme revealed that rupture of the covalent link does
not have any effect on the active site architecture or any other
part of the protein structure. Kinetic analysis, however, re-
vealed that the mutant enzyme displays a 10-fold decrease in
activity, which is due to a significantly lowered flavin redox
potential (265 mV) with respect to the wild-type enzyme (155
mV). This drastic decrease in redox potential can fully explain
the altered flavin reactivity, indicating that the covalent teth-
ering of the cofactor might have evolved to fine tune the redox
properties of the cofactor.
In the process of covalent His422-FAD bond formation, His-61
is thought to play an important role (8, 13). His-61 is envisaged
to deprotonate the neighboring His-422 as the shortest dis-
tance between the imidazole rings is only about 2.5 Å. By this,
His-422 is able to attack the activated 8a-methyl group of the
FAD cofactor creating the covalent linkage (12). To examine
the functional role of His-61 in the process of flavinylation, we
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have substituted this residue by a threonine. In this paper, we
report on the structural and catalytic properties of the H61T
mutant. Furthermore, it presents the first x-ray structural
studies of an apo form of a flavoenzyme that normally contains
a covalent FAD cofactor.
EXPERIMENTAL PROCEDURES
Chemicals, Bacterial Strains, and Plasmids—Escherichia coli strain
DH5F9 and the plasmids pUCBM20 (Roche Molecular Biochemicals)
and pGEM-5Zf(1) (Promega) were used for cloning throughout,
whereas E. coli strain TG2 and the plasmid pEMBL19(2) (Roche Mo-
lecular Biochemicals) were used for expression of the vaoA gene. Oli-
gonucleotides, T4 DNA ligase, restriction enzymes, isopropyl-b-D-thio-
galactopyranoside, yeast extract, and tryptone extract were from Life
Technologies, Inc. Forward M13 and reverse M13 sequencing primers
were from Amersham Pharmacia Biotech. Pwo DNA polymerase and
dNTPs were purchased from Roche Molecular Biochemicals, and Super
Taq DNA polymerase was purchased from HT Biotechnology. Ampicil-
lin, riboflavin, ADP, AMP, FMN, NAD1, and NADP1 were from Sigma.
4-(Methoxymethyl)phenol was obtained from Aldrich. All other chemi-
cals were from Merck and were of the purest grade available.
Analytical Methods—Site-directed mutagenesis was performed as
described previously (11). For the His-61 replacement by polymerase
chain reaction-based mutagenesis, the oligonucleotide 59 CGCAC-
GATCCCACTCATGTCATGGACCAGG 39 (where ACT denotes the
His-61 3 Thr replacement) was used. Successful mutagenesis was
confirmed by plasmid sequencing. The H61T mutant protein was ex-
pressed and purified as described previously (11). By extensive gel
permeation of holo H61T, virtually all FAD could be released. The FAD
content in the apoprotein preparations was ,0.1% as evidenced by the
flavin absorbance at 439 nm. Steady-state kinetic parameters of H61T
were determined by using saturating conditions for cofactor binding
(100 mM FAD), essentially as described earlier (7). Tryptophan fluores-
cence was measured using a Aminco SPF-500 fluorimeter.
Crystallization—Crystals were obtained using the hanging-drop va-
por diffusion method at similar conditions (4% w/v polyethylene glycol
4000, 100 mM sodium acetate/HCl, pH 5.1) that were used for crystal-
lizing wild-type VAO (14). Crystals of the H61T mutant in both the apo
and the holo form (size typically ;0.2 3 0.2 3 0.3 mm3) were isomor-
phous to those of wild-type enzyme, and they belong to space group I4.
Data Collection, Structural Determination, and Refinement—A com-
plete data set was collected at 100 K using a single crystal. Before
freezing, the crystals were briefly transferred to a solution containing
10% w/v polyethylene glycol 400, 5% w/v polyethylene glycol 4000, 10%
v/v glycerol, and 100 mM acetate/HCl, pH 5.1. Data were measured on
the following beam lines: beam line X11 of the Deutsches Elektronen-
Synchrotron/Europeon Molecular Biology Laboratory (Hamburg, Ger-
many) for the holoprotein crystal soaked in 1.0 mM 4-(trifluoro-
methyl)phenol and beam line ID14-EH3 of European Synchrotron
Radiation Facility (Grenoble, France) for the apoprotein and the ap-
oprotein soaked in 1.0 mM ADP. The structures were solved by differ-
ence Fourier methods and maximum likelihood refinement using REF-
MAC (15) and other CCP4 programs (16). Model building was carried
out using the program O (17), whereas positions of ordered water were
identified using the ARP program (18). Table I gives a summary of the
final refinement statistics. The free R-factor was calculated employing
the same reflections used for the free R-factor calculations in the re-
finement of the wild-type structure.
Coordinates—Coordinates have been deposited in the Protein Data
Bank (accession codes 1E8F, 1E8G, and 1E8H).
RESULTS AND DISCUSSION
Characterization of the His-61 3 Thr VAO Mutant—Purifi-
cation and characterization of H61T revealed that the mutation
did not abolish enzyme activity. However, it was found that
FIG. 1. Ribbons diagram of the overall structure of the VAO
monomer. The FAD-binding domain is shown in green, and the cap
domain is shown in red. The histidyl-bound FAD cofactor is shown in
ball-and-stick model. The picture was produced with MOLSCRIPT (26).
TABLE I
Statistics from the crystallographic analysis
Data set Apoenzyme ADP complex Holoenzyme
Resolution range (Å) 20–2.9 20–2.6 15–2.1
Observed reflections 54479 85638 151791
Unique reflections 23727 34320 57201
Data completeness (%)a 98.1 (98.1) 99.8 (99.6) 98.9 (99.7)
Multiplicity 2.3 (2.2) 2.5 (2.5) 2.5 (2.5)
Intensities (I/s) 5.2 (1.9) 5.2 (2.2) 5.9 (2.4)
Rsym (%)
a,b 10.5 (38.5) 9.0 (33.0) 6.6 (23.3)
Cell dimensions (Å) a 5 b 5 129.28 c 5 130.40 a 5 b 5 130.34 c 5 134.00 a 5 b 5 130.29 c 5 132.54
R-factor (%) 23.9 23.7 21.8
Rfree (%) 31.6 30.3 25.8
Number of water atoms 20 90 396
Number of ligand atoms 0 54 (ADP) 106 (FAD)
r.m.s.d. from idealityc 22 (4-(Trifluoromethyl)phenol)
Bond lengths (Å) 0.012 0.011 0.010
Bond angles (°) 2.8 2.4 2.2
Trigonal groups (Å) 0.023 0.021 0.020
Planar groups (Å) 0.011 0.010 0.009
Ramachandran plot (%)d 83.3/16.7/0 86.2/13.8/0 89.7/10.3/0
a The values relating to the highest resolution shell are given in parentheses.
b Rsym 5 Ij ^Ij&/^Ij&, where Ij is the intensity of an observation of reflection j and ^Ij& is the average intensity for reflection j.
c The root mean square deviations (r.s.m.d.) were calculated using the program REFMAC (15).
d Percentage of residues in most favored, allowed, and disallowed regions of the Ramachandran plot as checked with the program PROCHECK
(19).
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during the purification the protein readily lost activity, which
could be restored by supplementing the protein solution with
FAD. This indicated that the mutant has only a moderate
affinity for FAD. Unfolding of the purified protein confirmed
that no covalently bound FAD is formed in the H61T mutant
confirming the crucial role of this residue in the autocatalytical
covalent tethering of the prosthetic group. Kinetic analysis
revealed that the turnover rate of H61T was decreased by 1
order of magnitude when compared with wild-type VAO (Table
II). The effect on enzyme activity can well be explained by an
decreased redox potential of the cofactor due to the missing
covalent bond (11). In fact, the observed effect on the activity
was anticipated as it has been shown that merely disruption of
the covalent His-FAD bond results in a 10-fold decrease in
activity due to a changed redox potential of the cofactor, while
the mutation was not expected to have a direct effect on the
catalytic function of the enzyme as the respective residue is far
from the active site (distance between the imidazole ring of
His-61 and the FAD N5 atom is .10 Å). Unfortunately, at-
tempts to determine the redox potential of the mutant enzyme
were unsuccessful due the moderate affinity for FAD. As a
consequence a solution of the mutant enzyme contains rela-
tively large amounts of unbound FAD. Spectral interference of
the fraction of free FAD prevented an unambiguous redox
potential determination of the mutant enzyme.
The binding affinity for FAD to the mutant enzyme was
determined using tryptophan fluorescence quenching: Kd 5 1.8
mM. The noncovalent binding of the FAD cofactor could also be
demonstrated by the inhibitory effects of some FAD-related
compounds. Of all tested FAD derivatives (riboflavin, FMN,
NAD1, NADP1, AMP, and ADP) only the addition of AMP or
ADP resulted in a decreased enzyme activity. ADP was found
to be an effective competitive inhibitor, indicating that the FAD
binding largely depends on binding of the ADP moiety of the
cofactor, a frequently observed feature in FAD binding en-
zymes (20–22). Binding of ADP could also be measured by
using tryptophan fluorescence, showing a similar affinity (Kd 5
2.1 mM) when compared with FAD. The data for both FAD and
ADP binding were consistent with a single site binding process.
However, binding of ADP resulted in less fluorescence quench-
ing. This might be related to the fact that in the VAO structure,
Trp-413 is close to the isoalloxazine ring of FAD.
Due to the impairment in covalent flavinylation, the apo
form of H61T could be purified in large amounts, which opened
up possibilities to explore the process of FAD binding. Both the
apo and the holo form of H61T showed similar hydrodynamic
behavior: they form octamers of about 500 kDa (23) and can be
crystallized using similar conditions as found for wild-type
enzyme. By solving the crystal structures of both the apo- and
the holoenzyme (Table I), we have been able to examine the
structural effects associated with FAD binding.
Structure of the His-61 3 Thr VAO Holoenzyme—Compari-
son of the mutant holo form structure with the previously
solved wild-type structure (8) established that the His-61 re-
placement and the resulting missing covalent histidyl-FAD
bond does not induce gross conformational changes. Except for
a perturbation in the loop region Met64–Tyr68, displaying a
maximal shift of 4.5 Å, the Ca atoms superimpose with a root
mean square deviation of 0.46 Å for 910 equivalent positions
(i.e. the two VAO subunits present in the asymmetric unit). The
loop movement is far from both the cofactor, and the active site
and is probably caused by altered interactions due to the mu-
tation. The active site architecture and mode of flavin binding
of H61T is strictly conserved when compared with the wild-
type enzyme. These observations support the notion that by
mutating His-61 we have specifically inhibited the process of
covalent flavinylation, while the mutant has retained appre-
ciable activity. This also illustrates the dual catalytic potential
of VAO as the enzyme is able to catalyze two totally different
redox reactions: formation of the covalent histidyl-FAD bond
and oxidation of phenolic compounds. To explore the conserva-
tion of substrate binding, the crystals of holo H61T were soaked
in a solution containing 4-(trifluoromethyl)phenol, a competi-
tive inhibitor. Inspection of the electron density map showed
strong density for a bound 4-(trifluoromethyl)phenol molecule
in the active site. The benzylic ring of the substrate analog is
stacked almost parallel to the plane of the isoalloxazine ring
(13°), while the phenolic oxygen makes a hydrogen bond with
Tyr-503. As all fluorine atoms are resolved, it can be nicely seen
that one fluorine atom is directly pointing toward the reactive
N5 atom of the flavin ring (Fig. 2). The distance between the Ca
atom and the flavin N5 atom (3.7 Å) and the angles Ca-F-N5
(132°) and Ca-N5-N10 (114°) are fully compatible with a direct
hydride transfer, which is in line with the previously proposed
catalytic mechanism (7). Moreover, the observed orientation of
the ligand is similar to the binding mode of phenolic inhibitors
in other complexed VAO structures (8), confirming conserva-
tion of the active site architecture. To exemplify the high de-
gree of similarity of inhibitor binding between different ligan-
ded VAO structures, the isoeugenol complexed structures of
wild-type VAO (8) and the H422A VAO variant (11) (Protein
Data Bank entries 2VAO and 1QLU, respectively) were com-
pared with the 4-(trifluoromethyl)phenol complexed H61T
structure. Analysis of the superimposed active sites yields the
following key parameters for inhibitor binding: the hydrogen
bond distances between Tyr-503 and the hydroxyl group of the
ligands are 2.4, 2.7, and 2.5 Å respectively, the distances be-
tween flavin N5 and the Ca atom of the inhibitor is 3.5, 3.5, and
3.7 Å, respectively, while the phenolic ring is at a conserved
angle with respect to the plane of the isoalloxazine ring (18, 8,
and 13°, respectively).
TABLE II
Steady-state kinetic parameters of wild-type, H422A and H61T VAO
for the oxidation of 4-(methoxymethyl)phenol (50 mM potassium
phosphate buffer, pH 7.5, 25 °C)
Parameter Wild-typea H422Ab H61T
Km (mM) 55 34 40
kcat (s
21) 3.1 0.27 0.24
kcat/Km (mM
21zs21) 56 7.9 6.0
a Data from Ref. 7.
b Data from Ref. 11.
FIG. 2. The active site of the H61T ternary complex structure
showing all relevant residues, the isoalloxazine ring of the FAD
cofactor (yellow) and the bound 4-(trifluoromethyl)phenol
(blue) contoured by the 2Fo 2 Fc electron density calculated
with the refined model. The picture was generated with DINO (27).
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Structure of the Apoenzyme—Structure determination of the
apo form of H61T revealed a remarkable detailed resemblance
with the holoenzyme structure. Superposition of the Ca atoms
did not reveal any significant cofactor-induced conformational
change, which is reflected in a root mean square deviation of
only 0.33 Å. Consequently, a huge solvent-filled cavity (420 Å3)
is found in the apoenzyme structure complementary with the
missing cofactor (Fig. 3A). When the effect of FAD binding on
the active site architecture is taken under scrutiny, only a few
notable changes can be observed when compared with the
holoenzyme (Fig. 3B). Particularly, comparison between the
mutant holo and apo form structures shows that only the side
chains of Asn-105 and Ser-106 have altered positions, whereas
all other active site residues superimpose with a root mean
square deviation of ,0.4 Å. These results indicate that, prior to
binding of the cofactor, the apoprotein is fully folded, awaiting
FAD binding.
Along with the apoenzyme structure, also the structure of
the binary complex with ADP was determined at 2.6 Å. Similar
to FAD binding, binding of ADP did not induce any structural
changes as evidenced by a root mean square deviation of only
0.30 Å for all Ca atoms when compared with the apoenzyme
structure.
Holoenzyme Assembly—The cofactor binding capability of
the folded apoprotein could be demonstrated by soaking the
colorless apoenzyme crystals in a FAD containing solution.
Binding of FAD was completed within a few minutes as subse-
quent washing of the FAD soaked crystals resulted in bright
yellow crystals. Furthermore, these FAD reconstituted enzyme
crystals were also active as evidenced by substrate oxidation
upon incubation with 4-(methoxymethyl)phenol. Apparently,
the folded apoenzyme, even in the crystalline state, is mallea-
ble enough to allow the relatively large cofactor to enter the
preorganized binding pocket resulting in the active holoen-
zyme. However, although the active site is nearly conserved in
the apo form, soaking of apoenzyme crystals with substrate
analogs did not result in ligand binding. This indicates that the
positioning of the isoalloxazine ring system is a prerequisite for
substrate binding, which is different from the situation in e.g.
p-hydroxybenzoate hydroxylase (24, 25).
The similarity between the mutant structures in the holo
and apo form clearly indicate that FAD binding does not in-
volve an induced fit mechanism nor that the cofactor is re-
quired to attain the catalytically relevant conformation of the
active site. Rather, both cofactor and substrate bind via a
typical lock-and-key approach to highly preorganized binding
sites. The observed lock-and-key mechanism for FAD binding is
likely to apply to other flavoproteins. In particular, analysis of
the recently discovered flavoprotein family of VAO related pro-
tein sequences shows that the most conserved residues are
lining the FAD binding pocket (9), suggesting conservation in
the mechanism of flavinylation.
The reported crystallographic data provide detailed insight
in the protein-ligand interactions involved in flavin-mediated
catalysis. Combined with the recently solved structures of
VAO, we now have a clear view on the molecular trajectory of
enzyme assembly in VAO, which is composed of the following
steps: 1) the polypeptide folds and oligomerizes (23) to yield
apoprotein, 2) FAD is encapsulated by a highly preorganized
cofactor binding cavity, 3) autocatalytical covalent flavinyla-
tion results in cofactor activation enabling efficient redox ca-
talysis. By this, we have gained valuable information on the
process of flavin binding that will aid in understanding the
biological process of cofactor recognition, binding, and subse-
quent activation of apoenzymes.
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